Vera Therapeutics Inc’s recently made public that its Director SEIDENBERG BETH C unloaded Company’s shares for reported $0.58 million on Sep 19 ’24. In the deal valued at $42.31 per share,13,823 shares were sold. As a result of this transaction, SEIDENBERG BETH C now holds 146,553 shares worth roughly $6.53 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SEIDENBERG BETH C sold 1,476 shares, generating $61,992 in total proceeds. Upon selling the shares at $42.00, the Director now owns 4,012 shares.
Before that, SEIDENBERG BETH C sold 1,177 shares. Vera Therapeutics Inc shares valued at $49,448 were divested by the Director at a price of $42.01 per share. As a result of the transaction, SEIDENBERG BETH C now holds 160,376 shares, worth roughly $7.15 million.
Oppenheimer initiated its Vera Therapeutics Inc [VERA] rating to an Outperform in a research note published on January 25, 2024; the price target was $26. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. Raymond James began covering VERA with “an Outperform” recommendation on December 18, 2023. Jefferies revised its rating on November 10, 2023. It rated VERA as “a Buy” which previously was an “a Hold”.
Price Performance Review of VERA
On Monday, Vera Therapeutics Inc [NASDAQ:VERA] saw its stock jump 4.16% to $44.56. Over the last five days, the stock has gained 11.12%. Vera Therapeutics Inc shares have risen nearly 189.73% since the year began. Nevertheless, the stocks have risen 199.06% over the past one year. While a 52-week high of $50.78 was reached on 03/01/24, a 52-week low of $9.24 was recorded on 01/19/24. SMA at 50 days reached $37.60, while 200 days put it at $35.66.
Levels Of Support And Resistance For VERA Stock
The 24-hour chart illustrates a support level at 42.55, which if violated will result in even more drops to 40.54. On the upside, there is a resistance level at 45.93. A further resistance level may holdings at 47.30. The Relative Strength Index (RSI) on the 14-day chart is 71.85, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.82, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 7.31%. Stochastics %K at 92.93% indicates the stock is a selling.
How much short interest is there in Vera Therapeutics Inc?
A steep rise in short interest was recorded in Vera Therapeutics Inc stocks on 2024-08-30, dropping by 40330.0 shares to a total of 6.05 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 6.09 million shares. There was a decline of -0.67%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 16, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $27 price target.
